endovascular.es

Título: Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products
Fecha: 13-01-2015
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust covering PICC (peripherally inserted central catheter) and tip location devices. HealthTrust serves nearly 1,350 hospitals and members in more than 15,000 other locations, including surgery centers, physician practices, long-term care and alternate care sites. The agreement became effective January 1, 2015.
“At Teleflex, we are committed to providing high-quality, clinically relevant products that aim to enhance patient outcomes, reduce hospital costs and improve efficiencies”
Through this new agreement, HealthTrust members will have access to an extensive line of innovative ARROW®PICC and tip location devices, including the ARROW® PICC with Chlorag+ard® Technology and the ARROW®VPS® Vascular Positioning System®. The ARROW® PICC with Chlorag+ard® Technology has been shown to be effective in reducing microbial colonization and thrombus accumulation on catheter surfaces. A recent peer-reviewed study, published in the Fall 2014 issue of the Journal of the Association for Vascular Access (JAVA), demonstrated greater than 88 percent reduction in PICC-related bloodstream infections.1 The ARROW® VPS®Vascular Positioning System® uses a combination of advanced technologies. The VPS® Stylet, when used with the VPS® Console, provides real-time catheter tip location information by using the patient’s physiological (cardiac electrical activity and blood flow) information. Employing a simple user interface and Blue Bullseye symbol to indicate proper catheter tip placement, the technology is designed to avoid clinical consequences such as thrombosis, arterial puncture and vessel wall damage. The ARROW® VPS® Vascular Positioning System® is indicated for use as an alternate method to fluoroscopy or chest x-ray for central venous catheter tip placement confirmation in adult patients when a steady Blue Bullseye is obtained.
“At Teleflex, we are committed to providing high-quality, clinically relevant products that aim to enhance patient outcomes, reduce hospital costs and improve efficiencies,” said Jay White, President and General Manager, Vascular Division. White added, “We are pleased to continue achieving that goal through our relationship with HealthTrust, and ensuring more hospitals have access to technologies that help protect patients as well as the hospital’s bottom line.”
About HealthTrust
HealthTrust (legally known as HealthTrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total cost management solutions, including supply chain solutions and a contract and service portfolio unparalleled in quality, scope and value. HealthTrust (www.healthtrustpg.com) serves 1,350 acute care facilities and members in more than 15,000 other locations, including ambulatory surgery centers, physician practices, long-term care and alternate care sites. Headquartered in Brentwood, Tennessee, HealthTrust is closely integrated with the proven capabilities of Parallon Business Solutions, LLC (www.parallon.com), a leading provider of healthcare business and operational services, including revenue cycle management, workforce and technology solutions. On Twitter @healthtrustpg and @parallonconnect.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, Arrow, Chlorag+ard, VPS and Vascular Positioning System are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
© 2015 Teleflex Incorporated. All rights reserved. MC-000853
References:
1. Rutkoff GS. The Influence of an Antimicrobial Peripherally Inserted Central Catheter on Central Line-Associated Bloodstream Infections in a Hospital Environment. JAVA. 2014; Vol 19 No 3: 172-179

Contacts
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com
Fuente: endovascular.es

endovasculares.es